Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.95-$3.23 |
Market Cap | $261.2M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $6.4M |
Revenue Growth (YoY) | 9.2% |
Gross Profit (12 Mos) | -$77.9M |
Diluted EPS | -$1.05 |
News
See moreYahoo Finance • 17 days ago
Sector Update: Healthcare Stocks Edge Higher Premarket Friday
Yahoo Finance • last month
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Yahoo Finance • 2 months ago
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Fate Gets FDA IND Clearance For FT839 To Initiate Phase 1/2 Trial In Autoimmune Diseases
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
CFO | Mr. Kamal Adawi M.S., MBA |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |